ANI Pharmaceuticals (NASDAQ:ANIP) Price Target Raised to $86.00
ANI Pharmaceuticals (NASDAQ:ANIP – Free Report) had its price target increased by Guggenheim from $84.00 to $86.00 in a research report sent to investors on Wednesday,Benzinga reports. Guggenheim currently has a buy rating on the specialty pharmaceutical company’s stock. Several other research firms have also weighed in on ANIP. Leerink Partnrs upgraded shares of ANI […]
ANI Pharmaceuticals (NASDAQ:ANIP – Free Report) had its price target increased by Guggenheim from $84.00 to $86.00 in a research report sent to investors on Wednesday,Benzinga reports. Guggenheim currently has a buy rating on the specialty pharmaceutical company’s stock. Several other research firms have also weighed in on ANIP. Leerink Partnrs upgraded shares of ANI […]
